Cargando…

High‐Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry Disease

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079000/ https://www.ncbi.nlm.nih.gov/pubmed/27658941 http://dx.doi.org/10.1161/JAHA.116.002114

Ejemplares similares

High‐Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry Disease
por: Seydelmann, Nora, et al.
Publicado: (2016)

Cardiac Troponin I: A Valuable Biomarker Indicating the Cardiac Involvement in Fabry Disease
por: Tanislav, Christian, et al.
Publicado: (2016)

Continuous Cardiac Troponin I Release in Fabry Disease
por: Feustel, Andreas, et al.
Publicado: (2014)

Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy
por: Morrissey, Ryan P, et al.
Publicado: (2011)

Late-Stage Fabry Disease With Advanced Cardiomyopathy and Conduction Disorders
por: Mustafa, Saim, et al.
Publicado: (2023)

Correction: Coronary low-attenuation plaque and high-sensitivity cardiac troponin
Publicado: (2023)

Fabry Cardiomyopathy
por: Yoon, Jae Yong, et al.
Publicado: (2013)

Serum Biomarkers of Endothelial Dysfunction in Fabry Associated Cardiomyopathy
por: Loso, Jefferson, et al.
Publicado: (2018)

Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis
por: Maruyama, Hiroki, et al.
Publicado: (2019)

Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis
por: Maruyama, Hiroki, et al.
Publicado: (2018)

Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis
por: Maruyama, Hiroki, et al.
Publicado: (2018)

Correction to: Migalastat: A Review in Fabry Disease
por: McCafferty, Emma H., et al.
Publicado: (2019)

High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study
Publicado: (2016)

High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study
Publicado: (2015)

Biomarkers of Myocardial Fibrosis: Revealing the Natural History of Fibrogenesis in Fabry Disease Cardiomyopathy
por: Aguiar, Patrício, et al.
Publicado: (2018)

A Case of Fabry Cardiomyopathy
por: Nah, Jong Chun, et al.
Publicado: (2009)

Elevation of high‐sensitivity cardiac troponin T and left ventricular remodelling in hypertrophic cardiomyopathy
por: Kubo, Toru, et al.
Publicado: (2020)

Persistent increase in cardiac troponin I in Fabry disease: a case report
por: Tanislav, Christian, et al.
Publicado: (2011)

Patient selection for high sensitivity cardiac troponin testing and diagnosis of myocardial infarction: prospective cohort study
Publicado: (2018)

High sensitivity troponins and conventional troponins at the bedside
por: Bhoi, Sanjeev, et al.
Publicado: (2014)

Circulated TGF-β1 and VEGF-A as Biomarkers for Fabry Disease-Associated Cardiomyopathy
por: Ivanova, Margarita M., et al.
Publicado: (2023)

Immune‐Mediated Myocarditis in Fabry Disease Cardiomyopathy
por: Frustaci, Andrea, et al.
Publicado: (2018)

Differentiation of infiltrative cardiomyopathy from hypertrophic cardiomyopathy using high-sensitivity cardiac troponin T: a case-control study
por: Kubo, Toru, et al.
Publicado: (2015)

Fabry Disease Presenting with Hypertrophic Cardiomyopathy and Tricuspid Regurgitation
por: Cho, Sang-Cheol, et al.
Publicado: (2016)

Correction: Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease
por: Rob, Daniel, et al.
Publicado: (2017)

Biomarkers in Anderson–Fabry Disease
por: Simonetta, Irene, et al.
Publicado: (2020)

Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca(2+)-sensitivity and suppress the modulation of Ca(2+)-sensitivity by troponin I phosphorylation()
por: Messer, Andrew E., et al.
Publicado: (2016)

High-sensitive cardiac troponin T
por: Xu, Ru-Yi, et al.
Publicado: (2013)

Biomarkers of HFpEF: Natriuretic Peptides, High-Sensitivity Troponins and Beyond
por: Morfino, Paolo, et al.
Publicado: (2022)

Fabry Disease: More than a Phenocopy of Hypertrophic Cardiomyopathy
por: Stankowski, Kamil, et al.
Publicado: (2023)

Circulating Anti-GB3 Antibody as a Biomarker of Myocardial Inflammation in Patients with Fabry Disease Cardiomyopathy
por: Frustaci, Andrea, et al.
Publicado: (2023)

Correction to: High sensitivity troponin T and I reflect mitral annular plane systolic excursion being assessed by cardiac magnetic resonance imaging
por: Natale, Michèle, et al.
Publicado: (2018)

Left Ventricular Geometry and Blood Pressure as Predictors of Adverse Progression of Fabry Cardiomyopathy
por: Krämer, Johannes, et al.
Publicado: (2015)

Combined evaluation of coronary artery disease and high-sensitivity cardiac troponin T for prediction of adverse events in patients with hypertrophic cardiomyopathy
por: Liao, Hang, et al.
Publicado: (2021)

High sensitive troponine T as a biomarker and determinant factor of myocardial dysfunction in sepsis
por: Gonzalez Londoño, J, et al.
Publicado: (2015)

High sensitivity troponins: A potential biomarkers of cardiovascular risk for primary prevention
por: Leite, Luis, et al.
Publicado: (2022)

Measuring high-sensitivity cardiac troponin T blood concentration in population surveys
por: Lazzarino, Antonio Ivan, et al.
Publicado: (2017)

Elevated high-sensitivity cardiac troponin is associated with hypertrophy and fibrosis assessed with CMR in patients with hypertrophic cardiomyopathy
por: Gommans, Frank, et al.
Publicado: (2013)

Painful and painless myocardial ischemia detected by elevated level of high-sensitive troponin in patients with hypertrophic cardiomyopathy
por: Gębka, Adam, et al.
Publicado: (2018)

Long-term prognostic value of high-sensitivity cardiac troponin-I in patients with idiopathic dilated cardiomyopathy
por: Wang, Yongchao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2rntc64r8f4mkuluaoqc0m2b81